Mr. GP Singh, A global pharma CEO with 25+ years’ experience of successfully establishing and operating complex businesses. Before co-founding SHINKEI he has managed multiple types of pharmaceutical businesses across various geographies during his tenure at Jubilant Pharma as Global CEO. Prior to Jubilant, Singh had served as President of Sun Pharmaceuticals, US and as CEO of Caraco Pharma contributing to the growth of US businesses. GP has expertise in establishing world-class commercial, manufacturing and development organizations and lead them on growth path through inorganic and organic growth strategies.
Suresh Borsadia is a senior-level executive with more than 25 years’ experience in the pharmaceutical/drug delivery industry. He has a demonstrated track record of value creation and successful deal closings, supplemented with a background and experience in R&D. Prior to co-founding SHINKEI Therapeutics, he set-up Sun Pharma’s thin film technology capabilities, including commercial manufacturing. He co-founded Abeille after working for Lavipharm, TheraTech Inc (Teva) and Bertek Inc (Mylan) where he played a key role in R&D, in-licensing and out-licensing activities.
Kalpana has 25+ years of experience in technical portfolio management, alliance management, project management and product development. She is a leader with experience in development and implementation of strategic plans for drugs and devices, intellectual property, scale-up and manufacturing. Kalpana has worked in both large pharma (Wyeth and J&J) and small startups as well as consulted with companies of all sizes. Kalpana holds a Ph.D. in Pharmaceutical Sciences from the University of Iowa.